Contact us
Home / News Center / Page 3

News Center

News Center

Bobby Sheng and President Tsai Ing-wen
Business

Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen

Bora Pharmaceuticals honored at the "2023 Most Outstanding Company of the Year Awards" ceremony with Taiwan’s President Tsai Ing-wen.
cphi social
Events

CPhI Barcelona 2023

CPhI Barcelona 2023 Meet with Bora at CPhI October 24-26, 2023 Fira Barcelona Booth #3D38

BioJapan 2023
Events

Bio Japan 2023

Bio Japan 2023 Meet with Bora at Bio Japan October 11-13, 2023PACIFICO Yokohama, Japan Booth #B-19

contractpharma social
Events

22nd Annual Contracting & Outsourcing Conference

22nd Annual Contracting & Outsourcing Conference Meet with Bora at Contract Pharma 2023 September 21-22, 2023Hyatt Regency New Brunswick Table

Taoyuan unveiling
Business

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
9dab371d8d3507a5ed312a0f45bcb7dc
Business

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
image-missing
Business

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Establishing a lead position in Taiwan's CDMO sector
01c0ab94c8851f1209c04d14da155682
Business

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market

Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd.,

063d20c6b8277fcb15add84f63bcaa28
Business

Bora Pharmaceuticals to expand operations with $10m investment

TAIWAN – Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to

14f63859aed04039e1b49a3bb008360d
Business

Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan

TAIPEI, Taiwan, Dec. 3, 2021 /PRNewswire/ — Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin

64ff6baf33ee321d7610e547292b78b9
Business

KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan

Taipei, Taiwan, August 5, 2021 KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical

Bora

Contact

Address

  • 6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan
Youtube Linkedin

Quick Links

Copyright © 2025 Bora Pharmaceuticals. Developed by Engage.